Association Between Genetic Variation And Influenza Severity.

It is estimated that in the USA influenza -related deaths in recent years have ranged from 12,000 to 56,000. Factors like age, obesity, pregnancy and such chronic health conditions as asthma, chronic lung disease and heart disease are associated with an elevated risk of complications and death.

However, there are no proven genetic markers of influenza risk with an established mechanism of action. Interferon Induced Transmembrane Protein 3 (IFITM3) is an anti-viral protein that helps to block influenza infection of lung cells and to promote survival of the killer T cells that help clear the infection in the airways.

Image: A scanning electron micrograph of a CD8+ T cell engaging a virus.

(Photo courtesy of Dennis Kunkel).

A group of scientists collaborating with those at St. Jude Children's Research Hospital (Memphis, TN, USA) searched for other possible IFITM3 variants that correlated with gene expression, levels of the IFITM3 proteins and were common in influenza patients in the USA. The search led to an IFITM3 variant known as rs34481144. They checked 86 children and adults in Memphis with confirmed influenza infections and found two-thirds of patients with the most severe symptoms carried at least one copy of the newly identified high-risk IFITM3 variant. The high-risk variant was found in just 32% of patients with milder symptoms.

The team also found an association between the newly identified high-risk variant and severe and fatal influenza infections in 265 critically ill pediatric patients hospitalized in one of 31 intensive care units nationwide. The patients did not have health problems that put them at high risk for severe influenza. Of the 17 patients in this group who died from the infection, 14 carried at least one copy of the newly identified high-risk variant. Further study revealed how binding differed between the high-risk and protective variants. Those differences led to lower levels of the IFITM3 protein in individuals with two copies of the high-risk gene variant compared to other patients. The Memphis influenza patients also had fewer of the killer T cells in their upper airways. The study identifies a new regulator of IFITM3 expression that associates with CD8+ T cell levels in the airways and a spectrum of clinical outcomes.

Paul Thomas, PhD, an immunologist and corresponding author of the study, said, “A genetic marker of influenza risk could make a life-saving difference, particularly during severe influenza outbreaks, by helping prioritize high-risk patients for vaccination, drug therapy and other interventions. These results raise hopes that this newly identified IFITM3 variant might provide such a marker.” The study was published on July 17, 2017, in the journal Nature Medicine.

Source: labmedica

Screen Your Blood Cholesterol Levels For Your Heart Disease Risk!

Researchers have developed a first-of-its-kind rapid assay for measuring effectiveness of a patient’s high-density lipoprotein cholesterol (HDL-C) in cleaning up arterial cholesterol. This HDL-C function test could improve risk assessment and diagnosis, and help provide and monitor more personalized treatments for cardiovascular disease (CVD) patients.

Image: Research suggests a HDL-C function test could improve risk assessment and diagnosis,
and help provide and monitor more personalized treatments for CVD patients
(Photo courtesy of iStock).

While scientists have yet to fully elucidate how HDL-C helps protects against heart disease, one of its chief functions is thought to be mediating the removal of cholesterol from blood vessel walls. Recent studies have indicated that the ability of a patient’s HDL-C to do this – known as its cholesterol efflux capacity (CEC) – is a better gauge of CVD development than HDL-C levels on their own. This means, for example, that a patient with low levels of HDL-C but optimal CEC could be protected against heart disease to a greater degree than a patient with high levels of HDL-C but low CEC. However, the current standard research procedures for measuring CEC involve radioisotope-labeled cholesterol and cultured macrophages, making these methods too complex and time-consuming for clinical testing.

In this study, a team of researchers led by Amane Harada, PhD, of Sysmex Corporation (Kobe, Japan) and Ryuji Toh, MD, PhD, of Kobe University Graduate School of Medicine (Kobe, Japan) has developed a test for HDL-C function that is simple enough for clinical use. With a turnaround time of less than 6 hours, the test determines cholesterol uptake capacity (CUC) – the ability of HDL-C to accept additional cholesterol – which the researchers found correlates with CEC but is easier to measure. 

They evaluated their CUC test in 156 patients who had undergone revascularization (such as a stent or bypass) due to coronary artery disease and who had subsequently decreased their low-density lipoprotein cholesterol to a healthier level of less than 100 mg/dL. The study found that low CUC in these patients after treatment was significantly associated with the recurrence of coronary lesions. The researchers also determined that combining CUC with established CVD risk factors significantly improved the power of established factors to forecast which patients would redevelop heart disease.

If further trials validate this test, it could enable healthcare providers to use CUC in conjunction with HDL-C levels to better predict who is at risk for CVD onset or recurrence. This test could also be used to develop new treatments that increase CEC and to monitor their efficacy in patients.

“A more efficient enhancement of the atheroprotective functions of HDL may decrease the risk of atherosclerosis and [cardiovascular disease], although it has been difficult to develop therapeutic drugs with the expected effects,” wrote Harada and Toh in this paper, “We consider that this can be explained in part by the lack of a convenient assay system to evaluate HDL functionality without complicated or time-consuming procedures. In this respect, our cholesterol uptake assay provides a concise, accurate, and robust system for high-throughput analysis at low cost.”

The study, by Harada A et al, was published in the May 2017 issue of the Journal of Applied Laboratory Medicine.

Source: labmedica

Unnecessary Endoscopies Could Be Avoided with Fecal Blood Test

The majority of primary care patients referred for bowel endoscopy do not have significant colorectal disease (SCD), and are unnecessarily exposed to a small but realistic risk of severe endoscopy-associated complications.

Serious colorectal diseases, including colorectal cancer, are difficult to diagnose as the signs and symptoms are not always clear.

Read more: Unnecessary Endoscopies Could Be Avoided with Fecal Blood Test

The Quantum Blue rapid test allow for the immediate measurement of fecal calprotectin
(Photo courtesy of Bühlmann Laboratories).

Source: LabMedica

Genetic Testing Before Pregnancy Should Be as Common as Taking Folic Acid

Very few pre-pregnancy checklists include carrier screening as an important health item.

The very first time I had to tell a patient that she was at 25 percent risk of having a baby with cystic fibrosis, she was already 16 weeks pregnant. Only a few months prior, I had graduated and passed my board exam for genetic counseling. This was a "textbook case," as the saying goes. I reviewed the numbers with her and her husband: Odds were in their favor that this pregnancy would not be affected with cystic fibrosis. This couple wanted to know – they needed to know – with more certainty about what to expect. They were older first-time parents, and they agreed that they did not have the financial or emotional means to raise a child with a chronic health issue.

Read more: Genetic Testing Before Pregnancy Should Be as Common as Taking Folic Acid

Carrier screening should be universally offered in the preconception period, one expert argues.

Source: msn.com/en-us/health/medical

Does Going to the Hospital Make You Sicker?

During a hospital stay, people usually hope to have a medical condition treated effectively so they can recover fully, go home and stay home. But it's not uncommon for a hospitalization to lead to a new health problem that's serious enough to require hospital readmission within 30 days.

The phenomenon, dubbed "post-hospital syndrome" by Dr. Harlan Krumholz, a cardiologist and professor of medicine at the Yale School of Medicine, is roughly defined as an acquired, transient period of increased risk for illness after a hospital stay, one that leads to re-hospitalization.

Read more: Does Going to the Hospital Make You Sicker?

You could find yourself back in the hospital – because of the hospital (Getty Images).

Source: msn/health&fitness

Birth Control Without a Doctor's Visit? There's an App for That

Access to birth control is improving, but there are a few things to be aware of before proceeding.

While the issue of whether to allow hormonal contraceptives to be sold over the counter continues to be a political lightning rod, an access-improving development has quietly taken root without attracting controversy: An array of new apps and websites now make it possible for women to obtain prescription contraceptives in many states without having to schedule a doctor’s appointment. 

Thanks to game-changing program offerings from Nurx, Maven, Lemonaid, Virtuwell and Prjkt Ruby, women can answer questions about their health online or by video; the information is then reviewed by a doctor or nurse practitioner who will write a three-month prescription for oral contraceptives that patients can pick up at a nearby pharmacy or in some cases have delivered right to their homes.

Read more: Birth Control Without a Doctor's Visit? There's an App for That

Source: HealthUSNews

Identifying and Treating Inflammation

There are three types of inflammation: acute, chronic and life-threatening.

When basketball star Steph Curry slipped and injured his knee in late April, he reacted by tearing up on the sideline, while fans and media reacted by wondering how many games he would miss. His body? It reacted by inflaming around the outside of the knee, protecting the area as it recovered from a medial collateral ligament sprain.

The word inflammation can conjure up visuals of a swollen, red and throbbing knee or, thanks to some TV ads, a lit match doused by a medicated pad. Conventional public wisdom frames inflammation as being adverse, painful and harmful – something most people want to resolve quickly with medication.

Read more: Identifying and Treating Inflammation

Treat acute inflammation by managing it, not trying to cure it.

Source: Getty Images

Blood Test Uncovers Undiagnosed Diabetes In Hospital Patients

Hyperglycemia is a frequent finding that can be related to physiologic stress, illness and medications, including steroids and vasopressors and glycated hemoglobin (HbA1c) correlates with the average blood glucose level over the previous eight to 12 weeks.

Screening of HbA1c levels plays an important role in the diagnosis and management of diabetes mellitus in the outpatient setting but remains underused in the evaluation of hyperglycemia with undiagnosed diabetes in the inpatient setting.

Read more:   Blood Test Uncovers Undiagnosed Diabetes In Hospital Patients

A point-of-care glycated hemoglobin (HbA1C) analyzer.

Source: labmedica

DNA damage detected in patients after CT scanning.

Using new laboratory technology, scientists have shown that cellular damage is detectable in patients after CT scanning. In this study, researchers examined the effects on human cells of low-dose radiation from a wide range of cardiac and vascular CT scans. These imaging procedures are commonly used for a number of reasons, including management of patients suspected of having obstructive coronary artery disease, and for those with aortic stenosis, in preparation of transcatheter aortic valve replacement.

Using new laboratory technology, scientists have shown that cellular damage is detectable in patients after CT scanning, according to a new study led by researchers at the Stanford University School of Medicine.

"We now know that even exposure to small amounts of radiation from computed tomography scanning is associated with cellular damage," said Patricia Nguyen, MD, one of the lead authors of the study and an assistant professor of cardiovascular medicine at Stanford. "Whether or not this causes cancer or any negative effect to the patient is still not clear, but these results should encourage physicians toward adhering to dose reduction strategies."

Read more: DNA damage detected in patients after CT scanning.

Computed tomography (stock image). Along with the burgeoning use of advanced medical imaging
tests over the past decade have come rising public health concerns about possible links between low
dose radiation and cancer. The worry is that increased radiation exposure from such diagnostic
procedures as CT scans, which expose the body to low-dose X-ray beams, can damage DNA and
create mutations that spur cells to grow into tumors.

Source: Lilyana Vynogradova / Fotolia